30 May 2025
  • Blog
  • About
  • Contact
   
  • Current Topics
  • Social Media
  • Innovation
  • Medical Education
  • Residency
  • Research
Headline News
  • Doctors Day 2020 – Anything But Happy 31 Mar 2020
  • Social Media and Professionalism – Protecting Your Patients, Your Profession, and You 30 Oct 2018
  • Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match 24 Oct 2018
  • The Retina Society – 2018 Meeting Highlights 15 Sep 2018
  • Vitreoretinal Fellowship Match Survey – JAMA Ophthalmology 07 May 2018
  • home
  • blog
Researchers Use Skin Cells to Study Retinal Diseases

Researchers Use Skin Cells to Study Retinal Diseases

21 Dec 2012 eyesteve 0 4177

When world-renowned clinician scientist Edwin Stone MD, PhD at the University of Iowa asked a group of applicants to the ophthalmology residency program for questions, I curiously asked, “Which of your many research efforts are you most excited about?”

Dr. Stone scratched his head, thought for a few seconds, and responded, “Hmmm, good question. No one has ever asked me that question. Let me tell you about a current project that I am very excited about.”

One of the major challenges to studying the genetics of retinal diseases is the inability to study the function or dysfunction of gene products produced by cells in a living human retina. For scientists to study the gene products in patients with a specific disease, they often will use techniques such as that used in knockout mice to create a model of the disease in an animal. Unfortunately, no animal model currently exists to facilitate study of retinal diseases such as retinitis pigmentosa.

To overcome this challenge, Dr. Stone and his colleagues are using a technique borrowed from Zi-Bing Jin and others, wherein skin cells from a patient with retinitis pigmentosa are reprogrammed to become induced pluripotent stem cells (iPS). Using specific lab techniques, Dr. Stone and his colleagues are able to simulate the development of a retina that is able to survive outside of the human eye, thus circumventing the use of an animal model of retinitis pigmentosa and other retinal diseases. Despite his many scientific achievements, even Dr. Stone said that he was surprised when he observed the formation of human retinal tissue, complete with retinal progenitor, photoreceptor precursor, retinal pigment epithelium, and rod photoreceptor cells. This technique allows for the comparison of patients with diseased retinas to patients with healthy retinas, thus enabling scientists to study specific genes which may contribute to the development of retinal disease. In June 2011, Dr. Stone and others reported the use of this technique to investigate the mechanism whereby a homozygous mutation in the male germ-cell associated kinase (MAK) gene may have contributed to the development of retinitis pigmentosa.

The generation of pluripotent stem cells from patients with retinal diseases is a scientific advancement that will be of tremendous value to patients and ophthalmologists for many years to come. It is through such innovative approaches to studying ophthalmic disease that scientists like Dr. Stone will continue to unlock the mysteries contained within our genes, develop novel treatments involving gene-therapy, all with the goal to delay the onset or even cure genetically inherited eye disease.

Many thanks to Dr. Stone for sharing with us his excitement for stem cell and retina research. One of these days he may just walk into his lab and be surprised to find a complete iPS-derived eye staring right back!

Related

SHARE THIS ARTICLE :
Tweet

We would love to hear what you think! Post your questions or comments below!Cancel reply

ABOUT THE AUTHOR

eyesteve
  • ABOUT ME
  • OTHER ARTICLES
Steve Christiansen, MD, is a vitreoretinal surgeon practicing in Colorado Springs, Colorado. He previously completed ophthalmology residency at the University of Iowa Department of Ophthalmology & Visual Sciences in Iowa City, Iowa and fellowship at the Cincinnati Eye Institute in Cincinnati, Ohio.

Doctors Day 2020 – Anything But Happy

31 Mar 2020 eyesteve 1

Social Media and Professionalism – Protecting Your Patients, Your Profession, and You

30 Oct 2018 eyesteve 0

Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match

24 Oct 2018 eyesteve 0

The Retina Society – 2018 Meeting Highlights

15 Sep 2018 eyesteve 2
PREVIOUS

Innovations in Ophthalmology Resident Surgical Training

NEXT

Sudan Stops River Blindness With Mectizan

RELATED POST

The Retina Society – 2018 Meeting Highlights

15 Sep 2018 eyesteve 2

Vitreoretinal Fellowship Match Survey – JAMA Ophthalmology

07 May 2018 eyesteve 0

The Return of Private Equity to Ophthalmology

15 Nov 2017 eyesteve 0

Stem Cells and Treatment of Eye Disease – A Cautionary Tale

16 Mar 2017 Matt Weed 1

FIND EYESTEVE ON SOCIAL MEDIA

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Subscribe to EyeSteve

Latest Tweets From EyeSteve MD

Follow @eyesteve

EyeSteve.com Logo

EyeSteve.com was created to educate, inform, and inspire all things eye by discussing various aspects of medical education, informing patients about eye diseases and innovative new treatments, and inspiring us all toward vision health and appreciation of the wonderful gift of sight.

Recent Posts

  • Doctors Day 2020 – Anything But Happy
  • Social Media and Professionalism – Protecting Your Patients, Your Profession, and You
  • Reducing the Disclosure Effect in the Vitreoretinal Fellowship Match
  • The Retina Society – 2018 Meeting Highlights
  • Vitreoretinal Fellowship Match Survey – JAMA Ophthalmology

Get EyeSteve In Your Email

Subscribe to eyesteve.com and receive notifications of new posts instantly by email.

Follow @eyesteve
View Steven M. Christiansen's profile on LinkedIn
Copyright 2014 | eyesteve.com | All Rights Reserved | Powered by WordPress